3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
NIH
1
Study Type
Observational
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Breast Neoplasms
65
Neoplasms
56
Prostatic Neoplasms
44
Lung Neoplasms
35
Colorectal Neoplasms
35
Carcinoma, Non-Small-Cell Lung
24
Pancreatic Neoplasms
21
Hematologic Neoplasms
19
Head and Neck Neoplasms
16
Neoplasm Metastasis
15
Urinary Bladder Neoplasms
12
Ovarian Neoplasms
11
Stomach Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
10
Motor Activity
10
Triple Negative Breast Neoplasms
9
Multiple Myeloma
9
Colonic Neoplasms
9
Melanoma
8
Glioma
8
Anxiety Disorders
8
Uterine Cervical Neoplasms
7
Hematopoietic and Lymphatic System Neoplasm
7
Glioblastoma
7
Gastrointestinal Neoplasms
7
Esophageal Neoplasms
7
Anatomic Stage I Breast Cancer AJCC v8
7
Smoking Cessation
6
Sarcoma
6
Rectal Neoplasms
6
Interventions
Cyclophosphamide
81
fludarabine phosphate
77
Peripheral Blood Stem Cell Transplantation
62
Mycophenolic Acid
55
Tacrolimus
54
Whole-Body Irradiation
52
Busulfan
51
Antilymphocyte Serum
45
Cyclosporine
41
fludarabine
36
Methotrexate
32
Filgrastim
32
Melphalan
30
Radiotherapy
25
Methylprednisolone
19
Cytarabine
17
Cord Blood Stem Cell Transplantation
17
Sirolimus
15
Azacitidine
15
Granulocyte Colony-Stimulating Factor
14
Alemtuzumab
14
thymoglobulin
13
Flow Cytometry
13
Etoposide
13
Cyclosporins
13
Specimen Handling
10
Biopsy
10
Thiotepa
9
Psychiatric Rehabilitation
9
Decitabine
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Myeloproliferative Disorders
×
Standard of Care
×
Clear all
NCT04631458
2021-09-16
Mascot
Royal Free Hospital NHS Foundation Trust
Unknown
40 enrolled